Show simple item record

dc.contributor.authorWang, Yiranen_US
dc.contributor.authorZhang, Y-H Percivalen_US
dc.date.accessioned2012-08-24T12:00:23Z
dc.date.available2012-08-24T12:00:23Z
dc.date.issued2009-06-28
dc.identifier.citationBMC Biotechnology. 2009 Jun 28;9(1):58en_US
dc.identifier.urihttp://hdl.handle.net/10919/18895
dc.description.abstractBackground Cell-free protein synthesis (CFPS) is a rapid and high throughput technology for obtaining proteins from their genes. The primary energy source ATP is regenerated from the secondary energy source through substrate phosphorylation in CFPS. Results Distinct from common secondary energy sources (e.g., phosphoenolpyruvate - PEP, glucose-6-phosphate), maltodextrin was used for energizing CFPS through substrate phosphorylation and the glycolytic pathway because (i) maltodextrin can be slowly catabolized by maltodextrin phosphorylase for continuous ATP regeneration, (ii) maltodextrin phosphorylation can recycle one phosphate per reaction for glucose-1-phosphate generation, and (iii) the maltodextrin chain-shortening reaction can produce one ATP per glucose equivalent more than glucose can. Three model proteins, esterase 2 from Alicyclobacillus acidocaldarius, green fluorescent protein, and xylose reductase from Neurospora crassa were synthesized for demonstration. Conclusion Slowly-metabolized maltodextrin as a low-cost secondary energy compound for CFPS produced higher levels of proteins than PEP, glucose, and glucose-6-phospahte. The enhancement of protein synthesis was largely attributed to better-controlled phosphate levels (recycling of inorganic phosphate) and a more homeostatic reaction environment.en_US
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.rightsCreative Commons Attribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.titleCell-free protein synthesis energized by slowly-metabolized maltodextrinen_US
dc.typeArticle - Refereed
dc.date.updated2012-08-24T12:00:23Z
dc.description.versionPeer Reviewed
dc.rights.holderYiran Wang et al.; licensee BioMed Central Ltd.en_US
dc.title.serialBMC Biotechnology
dc.identifier.doihttps://doi.org/10.1186/1472-6750-9-58
dc.type.dcmitypeText


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International
License: Creative Commons Attribution 4.0 International